Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Alimta Market Status and Forecast (2016-2027)
  • 1.3.2 Global Alimta Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Alimta Supply by Company

• 2.1 Global Alimta Sales Volume by Company
• 2.2 Global Alimta Sales Value by Company
• 2.3 Global Alimta Price by Company
• 2.4 Alimta Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Alimta Market Status by Category

• 3.1 Alimta Category Introduction
  • 3.1.1 100mg
  • 3.1.2 500mg
• 3.2 Global Alimta Market by Category
  • 3.2.1 Global Alimta Sales Volume by Category (2016-2021)
  • 3.2.2 Global Alimta Sales Value by Category (2016-2021)
  • 3.2.3 Global Alimta Price by Category (2016-2021)
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Alimta Market Status by End User/Segment

• 4.1 Alimta Segment by End User/Segment
  • 4.1.1 Pleural Mesothelioma
  • 4.1.2 Non-small Cell Lung Cancer
• 4.2 Global Alimta Market by End User/Segment
  • 4.2.1 Global Alimta Sales Volume by End User/Segment (2016-2021)
  • 4.2.2 Global Alimta Sales Value by End User/Segment (2016-2021)
  • 4.2.3 Global Alimta Price by End User/Segment (2016-2021)
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Alimta Market Status by Region

• 5.1 Global Alimta Market by Region
  • 5.1.1 Global Alimta Sales Volume by Region
  • 5.1.2 Global Alimta Sales Value by Region
• 5.2 North America Alimta Market Status
• 5.3 Europe Alimta Market Status
• 5.4 Asia Pacific Alimta Market Status
• 5.5 Central & South America Alimta Market Status
• 5.6 Middle East & Africa Alimta Market Status

6 North America Alimta Market Status

• 6.1 North America Alimta Market by Country
  • 6.1.1 North America Alimta Sales Volume by Country (2016-2021)
  • 6.1.2 North America Alimta Sales Value by Country (2016-2021)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Alimta Market Status

• 7.1 Europe Alimta Market by Country
  • 7.1.1 Europe Alimta Sales Volume by Country (2016-2021)
  • 7.1.2 Europe Alimta Sales Value by Country (2016-2021)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Alimta Market Status

• 8.1 Asia Pacific Alimta Market by Country
  • 8.1.1 Asia Pacific Alimta Sales Volume by Country (2016-2021)
  • 8.1.2 Asia Pacific Alimta Sales Value by Country (2016-2021)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Alimta Market Status

• 9.1 Central & South America Alimta Market by Country
  • 9.1.1 Central & South America Alimta Sales Volume by Country (2016-2021)
  • 9.1.2 Central & South America Alimta Sales Value by Country (2016-2021)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Alimta Market Status

• 10.1 Middle East & Africa Alimta Market by Country
  • 10.1.1 Middle East & Africa Alimta Sales Volume by Country (2016-2021)
  • 10.1.2 Middle East & Africa Alimta Sales Value by Country (2016-2021)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Alimta Manufacturing Cost Analysis
• 11.5 Alimta Sales Channel and Distributors Analysis
  • 11.5.1 Alimta Sales Channel
  • 11.5.2 Alimta Distributors
• 11.6 Alimta Downstream Major Buyers

12 Global Alimta Market Forecast by Category and by End User/Segment

• 12.1 Global Alimta Sales Volume and Sales Value Forecast (2022-2027)
• 12.2 Global Alimta Forecast by Category
  • 12.2.1 Global Alimta Sales Volume Forecast by Category
  • 12.2.2 Global Alimta Sales Value Forecast by Category
  • 12.2.3 Global Alimta Price Forecast by Category
• 12.3 Global Alimta Forecast by End User/Segment
  • 12.3.1 Global Alimta Sales Volume Forecast by End User/Segment
  • 12.3.2 Global Alimta Sales Value Forecast by End User/Segment
  • 12.3.3 Global Alimta Price Forecast by End User/Segment

13 Global Alimta Market Forecast by Region/Country

• 13.1 Global Alimta Market Forecast by Region (2022-2027)
  • 13.1.1 Global Alimta Sales Volume Forecast by Region (2022-2027)
  • 13.1.2 Global Alimta Sales Value Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Eli Lilly
  • 14.1.1 Company Information
  • 14.1.2 Alimta Product Introduction
  • 14.1.3 Eli Lilly Alimta Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Eagle Pharmaceuticals
  • 14.2.1 Company Information
  • 14.2.2 Alimta Product Introduction
  • 14.2.3 Eagle Pharmaceuticals Alimta Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Cadila Healthcare
  • 14.3.1 Company Information
  • 14.3.2 Alimta Product Introduction
  • 14.3.3 Cadila Healthcare Alimta Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Abbott Healthcare
  • 14.4.1 Company Information
  • 14.4.2 Alimta Product Introduction
  • 14.4.3 Abbott Healthcare Alimta Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.4.4 SWOT Analysis

...

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Alimta market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Alimta market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
100mg
500mg

Segmented by End User/Segment
Pleural Mesothelioma
Non-small Cell Lung Cancer

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Eli Lilly
Eagle Pharmaceuticals
Cadila Healthcare
Abbott Healthcare